ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-12-11 | Pages: 200+ | Report ID: WR-2024-12-11-201080 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Adeno Associated Virus Vector Manufacturing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET
7.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Bayer AG
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 uniQure
16.3 Oxford Biomedica
16.4 Novartis AG
16.5 bluebird bio
16.6 AAVexis
16.7 REGENXBIO
16.8 Sanofi
16.9 Takara Bio
16.10 Janssen Biotech, Inc.
16.11 Bamboo Therapeutics
16.12 AskBio Therapeutics LLC
16.13 Pfizer
16.14 Solid Biosciences Inc.
16.15 Astellas Pharma
16.16 Roche
16.17 Audentes Therapeutics
16.18 WuXi AppTec
16.19 BioMarin Pharmaceutical
16.20 YPOSKESI
16.21 Sarepta Therapeutics
16.22 GenScript
16.23 LifeSpan BioSciences, Inc.
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Vector TypeSelf-complementary AAV Vectors
Single-stranded AAV Vectors
Hybrid AAV Vectors
By Application
Gene Therapy
Vaccine Development
Targeted Drug Delivery
Tissue Engineering
Cell Therapy
By Production Scale
Small-scale Manufacturing
Medium-scale Manufacturing
Large-scale Manufacturing
By Purification Method
Chromatography
Ultrafiltration
Nanoprecipitation
By Therapeutic Area
Genetic Disorders
Infectious Diseases
Neurological Disorders
Hematological Diseases
Ophthalmic Disorders
Companies
Bayer AG
uniQure
Oxford Biomedica
Novartis AG
bluebird bio
AAVexis
REGENXBIO
Sanofi
Takara Bio
Janssen Biotech, Inc.
Bamboo Therapeutics
AskBio Therapeutics LLC
Pfizer
Solid Biosciences Inc.
Astellas Pharma
Roche
Audentes Therapeutics
WuXi AppTec
BioMarin Pharmaceutical
YPOSKESI
Sarepta Therapeutics
GenScript
LifeSpan BioSciences, Inc.
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.